Primary bone cancer is a rare malignancy that starts in the bone itself, originating from the cells that form bone, cartilage, or other connective tissue within the skeleton. This distinguishes it from metastatic bone cancer, which is far more common in adults and occurs when cancers from other organs (breast, lung, prostate) spread to bone. Primary bone cancer accounts for a small fraction of all cancer diagnoses, but it has a significant impact because it often affects children, teenagers, and young adults.
How Primary Bone Cancer Differs From Bone Metastasis
When most adults are told they have “bone cancer,” it’s actually cancer that originated somewhere else and traveled to the bone. That’s metastatic bone cancer, and it behaves like whatever cancer it came from. Primary bone cancer is fundamentally different: the tumor grows from the bone’s own cells, specifically from primitive connective tissue cells called mesenchymal cells. This distinction matters because the two require completely different treatment approaches and carry different outlooks.
The Three Most Common Types
The World Health Organisation classifies primary bone tumors into six broad categories, but three types account for the vast majority of cases.
Osteosarcoma
Osteosarcoma is the most common primary bone cancer. It arises from bone-forming cells and is defined by its production of abnormal bone tissue. It can develop in any bone but most often appears near the ends of long bones, particularly around the knee and upper arm. Osteosarcoma is highly aggressive, most frequently striking adolescents and young adults during periods of rapid bone growth. A second, smaller peak occurs in older adults.
Chondrosarcoma
Chondrosarcoma grows from cartilage-producing cells. Unlike osteosarcoma, it’s primarily a disease of adults, most often diagnosed between ages 30 and 60. These tumors tend to be slower growing and are considered intermediate in aggressiveness. They rarely spread to distant sites, which gives them a generally more favorable outlook compared to other bone cancers. Chondrosarcomas commonly appear in the pelvis, upper leg, and shoulder area.
Ewing Sarcoma
Ewing sarcoma is an aggressive tumor that mainly affects children and adolescents. It belongs to a group of cancers made up of small, round cells, and while it most commonly arises in bone, it can also develop in surrounding soft tissues. The pelvis, thigh bone, and ribs are frequent sites. Ewing sarcoma grows quickly and requires prompt, intensive treatment.
Symptoms to Recognize
Pain is the most common symptom, though not all bone cancers cause it. The pain typically starts as intermittent and dull, often worse at night or during activity. Over weeks or months, it may become persistent and more intense. Many people initially assume it’s a sports injury or growing pains, which can delay diagnosis.
Other signs include a noticeable lump or swelling near a bone that may feel soft and warm to the touch. This swelling usually develops in the arms, legs, chest, or pelvis. Some people experience unexplained fever. In some cases, the first sign is a bone fracture that occurs without a clear cause or from only minor trauma, because the tumor has weakened the bone from within.
Risk Factors
For most people diagnosed with primary bone cancer, no clear cause is identified. However, several factors raise risk. Inherited genetic conditions, particularly those involving mutations in tumor-suppressing genes, are linked to osteosarcoma. Prior radiation therapy to a part of the body increases the risk of developing bone cancer in that area years later. Certain benign bone conditions can, in rare cases, transform into malignant tumors over time. The connection between rapid bone growth during puberty and osteosarcoma likely explains why tall adolescents appear to face slightly higher risk.
How It’s Diagnosed
Diagnosis typically begins with imaging. X-rays can reveal suspicious bone destruction or abnormal bone formation, while MRI provides detailed views of the tumor’s size and its relationship to surrounding muscles, nerves, and blood vessels. CT scans and PET scans help determine whether the cancer has spread beyond the original site. A bone scan may also be used to check for additional areas of involvement throughout the skeleton.
Imaging alone cannot confirm bone cancer. A biopsy is essential, either through a needle inserted through the skin or through a small surgical incision. The biopsy requires careful planning because a poorly placed incision can complicate future surgery. For this reason, it’s important that the biopsy be performed at a center experienced in treating bone cancers, ideally by the same team that would handle surgical treatment.
Staging
Once confirmed, the cancer is staged to guide treatment. Bone cancers use a staging system that considers three factors: the tumor’s grade (how aggressive the cells look under a microscope), whether the tumor is still contained within the bone or has extended into surrounding tissue, and whether it has spread to distant sites.
Stages I and II describe cancers that haven’t spread. Stage I tumors are low grade, meaning they grow more slowly. Stage II tumors are high grade and more aggressive. Each is further divided based on whether the tumor remains inside the bone (A) or has pushed beyond it (B). Stage III applies to any tumor that has spread to lymph nodes or distant organs, regardless of grade or size.
Treatment Approach
Treatment for primary bone cancer almost always involves surgery, often combined with chemotherapy. The specific plan depends on the cancer type, its location, and how far it has spread.
For osteosarcoma, treatment generally follows a three-phase approach. Chemotherapy is given first to shrink the tumor and reduce surrounding inflammation. This makes surgery more effective and helps preserve as much healthy tissue as possible. Surgery follows, with the goal of removing the entire tumor along with a margin of normal bone, typically at least 3 centimeters beyond the tumor’s visible edge on MRI. After surgery, additional rounds of chemotherapy are given to target any remaining cancer cells. Doctors assess how well the initial chemotherapy worked by examining how much of the tumor was killed. If less than 90% of the tumor tissue is dead, the post-surgery chemotherapy regimen may be adjusted.
Limb-sparing surgery is now the standard for most patients. Rather than amputation, surgeons remove the affected bone segment and reconstruct it using metal implants, bone grafts from the patient’s own body, or donor bone. This approach preserves the limb’s function while still achieving safe margins around the tumor. Amputation remains necessary in some cases, particularly when the tumor involves critical nerves or blood vessels that can’t be preserved.
Chondrosarcoma is treated primarily with surgery because these tumors generally respond poorly to chemotherapy and radiation. Ewing sarcoma, being highly aggressive, requires intensive chemotherapy alongside surgery and sometimes radiation therapy.
Survival Rates by Type
Survival varies significantly depending on the type of bone cancer and how far it has spread at diagnosis. Based on data from patients diagnosed between 2015 and 2021:
- Chondrosarcoma: 91% five-year survival when localized, dropping to 28% when it has spread to distant sites.
- Chordoma (a rare type arising from remnants of embryonic spine tissue): 94% five-year survival when localized, 54% when distant.
- Giant cell tumor of bone: 91% five-year survival when localized, 39% when distant.
These numbers reflect relative survival, meaning they compare people with bone cancer to the general population of the same age. Localized disease consistently carries a much better prognosis, which underscores the value of catching these cancers before they spread. Early, persistent bone pain that doesn’t respond to rest or typical treatments deserves medical attention, particularly in young people.